drugset / Trial / NCT05747339
A Clinical Study on the Efficacy and Mechanism of Tumor Treatment Vaccine (TTV) for Recurrent and Refractory Advanced Solid Tumors
NaSingle-groupOpen-labelTreatment
Summary
This is a study of the clinical efficacy and mechanism study of tumor treatment vaccine (TTV, also known as Neo-BCV) in patients with recurrent and refractory advanced solid tumors.
Timeline
- Start
- 2023-06-07
- Primary completion
- 2024-12-31
- Completion
- 2024-12-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Neo-BCV | Vaccine | 1 ml | Subcutaneous |
| Subject | Neo-BCV | Vaccine | 2.5 ml | Subcutaneous |
| Subject | Neo-BCV | Vaccine | 4 ml | Subcutaneous |
Indications
No indication recorded.